Abstract
To identify cancer-specific targets, we have conducted a synthetic lethal screen using a small interfering RNA (siRNA) library targeting ∼4,000 individual genes for enhanced killing in the DLD-1 colon carcinoma cell line that expresses an activated copy of the K-Ras oncogene. We found that siRNAs targeting baculoviral inhibitor of apoptosis repeat-containing 5 (survivin) significantly reduced the survival of activated K-Ras-transformed cells compared with its normal isogenic counterpart in which the mutant K-Ras gene had been disrupted (DKS-8). In addition, survivin siRNA induced a transient G2-M arrest and marked polyploidy that was associated with increased caspase-3 activation in the activated K-Ras cells. These results indicate that tumors expressing the activated K-Ras oncogene may be particularly sensitive to inhibitors of the survivin protein. Copyright © 2007 American Association for Cancer Research.
Cite
CITATION STYLE
Sarthy, A. V., Morgan-Lappe, S. E., Zakula, D., Vernetti, L., Schurdak, M., Packer, J. C. L., … Fesik, S. W. (2007). Survivin depletion preferentially reduces the survival of activated K-Ras-transformed cells. Molecular Cancer Therapeutics, 6(1), 269–276. https://doi.org/10.1158/1535-7163.MCT-06-0560
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.